Melanasa (Hydroquinone)

Melanasa is a topical skin depigmenting agent used to address disorders of melanin overproduction. It is indicated for the following conditions:

• Melasma: helps lighten brown patches on the face and improve overall skin tone.
• Age spots: reduces the appearance of solar lentigines and other age‑related pigmentations.
• Post‑inflammatory hyperpigmentation: diminishes dark spots that develop after skin injury or inflammation.

• Hydroquinone inhibits the activity of the enzyme tyrosinase within melanocytes, which is essential for the conversion of tyrosine to melanin. By blocking this step, melanin synthesis is reduced, leading to a gradual lightening of hyperpigmented skin areas when applied topically over a period of consistent use.

Hydroquinone may cause a range of skin reactions, from mild irritation to rare but serious events.

Common Side Effects

• Skin irritation: mild redness or burning at the application site.
• Dryness: increased skin dryness or flaking.
• Itching: localized pruritus.
• Peeling: superficial desquamation of treated skin.
• Contact dermatitis: eczema‑like rash.
• Increased photosensitivity: heightened reaction to sunlight.

Serious or Rare Side Effects

• Exogenous ochronosis: permanent darkening of the skin with prolonged use.
• Severe allergic reaction: swelling, hives, or difficulty breathing.
• Persistent hyperpigmentation: paradoxical darkening of treated areas.
• Secondary infection: bacterial infection of compromised skin.
• Scarring: rare development of permanent skin marks.
• Systemic absorption effects: unlikely but reported in extensive application over large body surface.

When using Melanasa, consider the following safety measures:

• Sun exposure: avoid direct sunlight and use broad‑spectrum sunscreen.
• Application area: do not apply to broken, inflamed, or infected skin.
• Duration of use: limit continuous treatment to the period recommended by a healthcare professional.
• Concomitant products: avoid using other bleaching or irritating skin products simultaneously.
• Monitoring: discontinue if severe irritation or allergic signs develop.
• Store at room temperature: keep in the original container, protect from moisture and direct light.

Hydroquinone can interact with other topical agents, affecting tolerability or efficacy.

Major Interactions (Avoid)

• Combined use with other depigmenting agents (e.g., tretinoin, corticosteroids) may increase irritation risk.
• Application over chemical peels or laser-treated skin can cause severe burns.
• Use with strong acids (glycolic, salicylic) may exacerbate skin damage.

Moderate Interactions (Monitor Closely)

• Concurrent use of sunscreen enhances safety and effectiveness.
• Mild irritants (e.g., fragrance‑rich moisturizers) may require monitoring for additive irritation.
• Use with systemic photosensitizing drugs warrants caution and sun protection.
• Co‑administration with other topical antioxidants generally safe but observe for unexpected reactions.